Notify me when PFM Health Sciences, LP files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 77 | $987,699,528 | +$298,819,380 | -$690,356,218 | -$391,536,838 | THC, LLY, AXSM, PEN, ASND | 13F-HR | 17 Feb 2026, 16:15 |
| Q3 2025 | 67 | $1,172,645,138 | +$297,041,573 | -$363,918,250 | -$66,876,677 | LLY, THC, AXSM, MCK, PEN | 13F-HR | 14 Nov 2025, 16:20 |
| Q2 2025 | 56 | $1,154,335,512 | +$239,502,459 | -$439,977,443 | -$200,474,984 | LLY, THC, MCK, AXSM, ISRG | 13F-HR | 14 Aug 2025, 16:01 |
| Q1 2025 | 64 | $1,303,689,196 | +$262,855,231 | -$313,395,965 | -$50,540,734 | LLY, ABBV, THC, MCK, AXSM | 13F-HR | 15 May 2025, 16:09 |
| Q4 2024 | 73 | $1,312,757,286 | +$249,141,955 | -$544,979,270 | -$295,837,315 | LLY, THC, ABBV, MCK, VRTX | 13F-HR | 14 Feb 2025, 16:25 |
| Q3 2024 | 74 | $1,743,199,557 | +$127,506,926 | -$287,057,401 | -$159,550,475 | LLY, THC, CYTK, ABBV, VRTX | 13F-HR | 14 Nov 2024, 17:03 |
| Q2 2024 | 74 | $1,834,834,556 | +$222,279,391 | -$296,464,789 | -$74,185,398 | LLY, CYTK, THC, MRK, VRTX | 13F-HR | 14 Aug 2024, 16:01 |
| Q1 2024 | 83 | $2,010,575,107 | +$311,828,364 | -$155,945,173 | +$155,883,191 | LLY, CYTK, MRK, ABBV, EW | 13F-HR | 14 May 2024, 16:12 |
| Q4 2023 | 63 | $1,667,158,944 | +$228,833,484 | -$916,467,574 | -$687,634,090 | LLY, CYTK, MRK, ABBV, VRTX | 13F-HR | 14 Feb 2024, 16:03 |
| Q3 2023 | 70 | $2,090,890,666 | +$199,025,885 | -$459,062,646 | -$260,036,761 | LLY, HUM, ABBV, CYTK, MRK | 13F-HR | 14 Nov 2023, 16:15 |
| Q2 2023 | 79 | $2,486,762,535 | +$456,541,629 | -$298,209,532 | +$158,332,097 | LLY, PEN, HZNP, CYTK, CNC | 13F-HR | 14 Aug 2023, 16:03 |
| Q1 2023 | 74 | $2,170,642,964 | +$309,033,673 | -$403,318,912 | -$94,285,239 | HZNP, LLY, PEN, CYTK, HUM | 13F-HR | 15 May 2023, 16:04 |
| Q4 2022 | 78 | $2,368,819,007 | +$243,183,710 | -$599,156,823 | -$355,973,113 | HZNP, CYTK, LLY, CNC, HUM | 13F-HR | 14 Feb 2023, 16:06 |
| Q3 2022 | 80 | $2,614,409,000 | +$415,075,997 | -$381,534,213 | +$33,541,784 | CYTK, LLY, BMRN, RCUS, CNC | 13F-HR | 14 Nov 2022, 16:03 |
| Q2 2022 | 75 | $2,561,837,000 | +$579,990,602 | -$341,599,093 | +$238,391,509 | JNJ, CYTK, LLY, CNC, JAZZ | 13F-HR | 15 Aug 2022, 17:23 |
| Q1 2022 | 67 | $2,590,318,000 | +$383,786,652 | -$413,242,808 | -$29,456,156 | OM, HZNP, RCUS, JNJ, CNC | 13F-HR | 16 May 2022, 16:03 |
| Q4 2021 | 69 | $2,867,842,000 | +$386,487,835 | -$636,413,813 | -$249,925,978 | RCUS, OM, ABBV, HZNP, CYTK | 13F-HR | 14 Feb 2022, 16:37 |
| Q3 2021 | 75 | $3,080,193,000 | +$486,177,743 | -$585,546,345 | -$99,368,602 | HZNP, OM, LLY, RCUS, CYTK | 13F-HR | 15 Nov 2021, 16:05 |
| Q2 2021 | 79 | $3,107,273,000 | +$418,837,831 | -$329,905,906 | +$88,931,925 | ALXN, HZNP, OM, LLY, NBIX | 13F-HR | 16 Aug 2021, 16:03 |
| Q1 2021 | 76 | $2,870,447,000 | +$826,470,023 | -$459,905,608 | +$366,564,415 | OM, ALXN, HZNP, NBIX, ABBV | 13F-HR | 17 May 2021, 16:02 |
| Q4 2020 | 70 | $2,420,318,000 | +$819,766,244 | -$511,761,852 | +$308,004,392 | ALXN, OM, ABBV, HZNP, RCUS | Restatement | 19 Feb 2021, 16:02 |
| Q3 2020 | 66 | $1,888,384,000 | +$665,460,509 | -$628,987,184 | +$36,473,325 | OM, IMMU, HZNP, ALXN, GILD | 13F-HR | 16 Nov 2020, 16:02 |
| Q2 2020 | 64 | $1,627,985,000 | +$631,950,077 | -$437,312,533 | +$194,637,544 | IMMU, ALXN, HZNP, ABBV, BMRN | 13F-HR | 14 Aug 2020, 16:06 |
| Q1 2020 | 60 | $1,211,569,000 | +$509,860,341 | -$899,983,418 | -$390,123,077 | ALXN, ABBV, ELV, MCK, BIOMARIN PHARMACEUTICAL INC | 13F-HR | 15 May 2020, 16:10 |
| Q4 2019 | 56 | $1,733,114,000 | +$564,853,632 | -$2,466,335,635 | -$1,901,482,003 | ALXN, GILD, BOLD, PEN, NVRO | 13F-HR | 14 Feb 2020, 17:05 |
| Q3 2019 | 70 | $3,276,361,000 | +$1,421,964,003 | -$2,073,073,195 | -$651,109,192 | NOVO-NORDISK A S, BMRN, ALXN, PEN, ZBH | 13F-HR | 14 Nov 2019, 16:11 |
| Q2 2019 | 78 | $4,116,363,000 | +$1,545,361,944 | -$1,169,085,782 | +$376,276,162 | AGN, BMRN, HUM, ZBH, WCG | 13F-HR | 14 Aug 2019, 16:04 |
| Q1 2019 | 84 | $3,673,746,000 | +$1,377,943,164 | -$1,763,628,223 | -$385,685,059 | ARNA, ZBH, PFE, SYK, UNH | 13F-HR | 15 May 2019, 16:06 |
| Q4 2018 | 91 | $3,456,420,000 | +$1,036,287,343 | -$2,754,857,486 | -$1,718,570,143 | GDDY, ELV, ARNA, HUM, PEN | 13F-HR | 14 Feb 2019, 16:59 |
| Q3 2018 | 110 | $5,849,105,000 | +$1,410,154,130 | -$1,186,608,150 | +$223,545,980 | MYL, JAZZ, ELV, AERI, PCRX | 13F-HR | 13 Nov 2018, 16:01 |
| Q2 2018 | 105 | $5,387,556,000 | +$1,492,760,664 | -$1,120,088,128 | +$372,672,536 | JAZZ, PTLA, AERI, ELV, MYL | 13F-HR | 14 Aug 2018, 16:03 |
| Q1 2018 | 89 | $4,651,912,000 | +$1,776,049,019 | -$1,129,640,603 | +$646,408,416 | BMY, MYL, PTLA, JAZZ, AERI | 13F-HR | 15 May 2018, 16:08 |
| Q4 2017 | 74 | $3,938,687,000 | +$1,213,747,908 | -$1,444,215,053 | -$230,467,145 | PTLA, PBYI, AERI, EW, ABT | 13F-HR | 14 Feb 2018, 16:19 |
| Q3 2017 | 79 | $4,028,828,000 | +$1,507,917,156 | -$1,261,577,334 | +$246,339,822 | PTLA, PBYI, ELV, AERI, BPMC | 13F-HR | 14 Nov 2017, 16:09 |
| Q2 2017 | 84 | $3,407,493,000 | +$1,313,872,792 | -$1,873,907,371 | -$560,034,579 | KITE, PTLA, PBYI, ELV, BABA | 13F-HR | 14 Aug 2017, 16:19 |
| Q1 2017 | 92 | $3,708,864,000 | +$1,800,261,443 | -$1,377,194,087 | +$423,067,356 | MRVL, JAZZ, LBTYA, BIIB, WFTIQ | 13F-HR | 15 May 2017, 16:10 |
| Q4 2016 | 85 | $3,004,875,000 | +$1,270,199,226 | -$1,438,590,089 | -$168,390,863 | BIIB, CI, JAZZ, MDCO, BMRN | 13F-HR | 14 Feb 2017, 16:28 |
| Q3 2016 | 79 | $3,281,227,000 | +$1,510,124,302 | -$1,192,537,236 | +$317,587,066 | BIIB, JAZZ, META, EW, UNP | 13F-HR | 14 Nov 2016, 16:36 |
| Q2 2016 | 66 | $2,616,789,000 | +$1,295,176,745 | -$1,569,255,654 | -$274,078,909 | AET, EW, ALDR, META, AMAT | 13F-HR | 15 Aug 2016, 16:20 |
| Q1 2016 | 73 | $2,847,076,000 | +$1,255,900,018 | -$1,377,695,939 | -$121,795,921 | HCA, ABBV, AAPL, BMY, WBA | 13F-HR | 16 May 2016, 16:04 |
| Q4 2015 | 65 | $3,219,379,000 | +$1,234,815,687 | -$1,534,907,966 | -$300,092,279 | BMY, WBA, AGN, PANW, AER | 13F-HR | 16 Feb 2016, 16:25 |
| Q3 2015 | 66 | $3,547,587,000 | +$1,324,221,009 | -$1,482,167,924 | -$157,946,915 | CLVSQ, HCA, WBA, UNH, PFE | 13F-HR | 16 Nov 2015, 16:22 |
| Q2 2015 | 83 | $3,941,869,000 | +$1,658,713,266 | -$1,554,725,232 | +$103,988,034 | CLVSQ, HCA, AER, BRCM, BMY | 13F-HR | 14 Aug 2015, 16:21 |
| Q1 2015 | 81 | $3,625,211,000 | +$1,300,307,283 | -$2,377,290,295 | -$1,076,983,012 | CLVSQ, VMC, VRX, WBA, MIC | 13F-HR | 15 May 2015, 16:19 |
| Q4 2014 | 87 | $4,281,289,000 | +$2,014,207,292 | -$2,335,524,481 | -$321,317,189 | VMC, MSFT, VRX, HCA, WBA | 13F-HR | 17 Feb 2015, 16:06 |
| Q3 2014 | 62 | $4,341,974,000 | +$1,003,634,059 | -$1,772,008,213 | -$768,374,154 | VMC, VRX, HOT, NFLX, HCA | 13F-HR | 14 Nov 2014, 16:29 |
| Q2 2014 | 64 | $5,000,812,000 | +$2,110,605,140 | -$2,683,371,691 | -$572,766,551 | AGN, RAD, VMC, HOT, MLM | 13F-HR | 14 Aug 2014, 16:21 |
| Q1 2014 | 71 | $5,515,272,000 | +$3,167,842,258 | -$2,756,333,331 | +$411,508,927 | EEM, BMY, GOOGL, HCA, HOT | 13F-HR | 15 May 2014, 16:34 |
| Q4 2013 | 60 | $4,971,813,000 | +$2,417,986,552 | -$1,968,323,372 | +$449,663,180 | BMY, GILD, GOOGL, HOT, A | Restatement | 21 Feb 2014, 16:05 |
| Q3 2013 | 68 | $4,150,952,000 | +$1,329,045,486 | -$2,438,244,721 | -$1,109,199,235 | GILD, TMO, HOT, A, WYND | Restatement | 21 Feb 2014, 16:04 |
| Q2 2013 | 70 | $4,812,890,000 | +$2,670,330,952 | -$873,250,432 | +$1,797,080,520 | GILD, ETN, PFE, GOOGL, TMO | Restatement | 21 Feb 2014, 16:04 |
| Q1 2013 | 58 | $3,021,937,000 | $0 | $0 | $0 | CTXS, GILD, PFE, ETN, CBRE | Restatement | 21 Feb 2014, 16:04 |